Since the lower release of NfL and subsequent lower increase of sNfL levels in progressive disease is a mechanism independent of the underlying pathobiology, it may also occur in PPMS and explain the vanishing difference in sNfL levels compared to SPG4. The gene discussed is SPAST; the disease is primary progressive multiple sclerosis.